Biological treatment interruption in inflammatory bowel disease: Motivation and predictive factors.

Autor: Davis González MR; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain., Ballester MP; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain; Instituto de Investigación Sanitaria INCLIVA, Spain. Electronic address: mapibafe@gmail.com., Romero-González E; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain., Sánchez-Pardo AM; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain., Marti-Aguado D; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain., Tosca J; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain., Suria C; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain., Antón Ausejo R; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain., Pascual Moreno I; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain., Planelles Silvestre MD; Histocompatibility Laboratory, Transfusion Center of Valencian Community, Valencia, Spain., Mínguez Pérez M; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain., Bosca-Watts MM; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain.

Publikováno v: Gastroenterologia y hepatologia [Gastroenterol Hepatol] 2023 Nov; Vol. 46 (9), pp. 671-681. Date of Electronic Publication: 2022 Nov 11.